Cempra, Inc. To Present At Barclays Capital 2014 Global Healthcare Conference And 26th Annual ROTH Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHAPEL HILL, N.C., March 6, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at the Barclays Capital 2014 Global Healthcare Conference at 3:45 p.m. EST, Wednesday, March 12, at the Loews Miami Hotel in Miami Beach, Fla. and at the 26th Annual ROTH Conference at 3:30 p.m. PST, Monday, March 10, at The Ritz Carlton in Laguna Niguel, Calif. Dr. Fernandes will discuss the company's two differentiated antibiotics, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA (CEM-102 or fusidic acid) for the chronic, oral treatment of Gram-positive pathogens including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC